Cited by 470Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchMental Health and Psychiatry

A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives

Benes, Francine M, Kwok, Esther W, Vincent, Stephen L, Todtenkopf, Mark S·1998·Biological Psychiatry

Abstract

Background Recent studies have suggested that there may be a preferential decrease of "nonpyramidal" neurons (NPs) in several corticolimbic regions of schizophrenic (SZ) brain. The current study was undertaken to determine whether a change in the density of pyramidal neurons (PNs) and NPs might be present in the hippocampal formation (HIPP) of SZ brain.Methods A spatial counting approach in which the location of each and every PN and NP in the stratum pyramidale of sectors CA1-4 was applied to 11 normal control (CONs) and 10 SZs matched for age and postmortem interval, as well as 4 manic depressive (MD) subjects matched for age.Results The data indicate that the CONs had approximately 10-20 times as many PNs than NPs in the various HIPP subfields. When the CON data were compared to those for the SZs, both the total number and density of PNs were found to be similar in all four sectors, while NPs were found to be selectively reduced by approximately 40% in CA2 of the SZ group. When the data were broken down according to patients with and without neuroleptic exposure, drug-free SZs showed a significant reduction in the density of NPs in CA2. The 4 MD cases both with and without neuroleptic exposure also showed a similar reduction of NPs in sector CA2.Conclusions Taken together, the results of this study suggest that there may be a highly selective decrease in the number of NPs in sector CA2 that could play a contributory role in the pathophysiology of the major psychoses.

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(98)00138-3

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The possibility that CA2 dysfunction contributes to neuropsychiatric behavioral changes is supported by findings of decreased CA2 inhibitory neurons in individuals with schizophrenia and bipolar disorder and altered vasopressin signaling in autism.

    “This possibility is supported by findings of a decreased number of CA2 inhibitory neurons in individuals with schizophrenia and bipolar disorder29 and altered vasopressin signaling in autism30.”

    From The hippocampal CA2 region is essential for social memory (2014) · cites this paper as [29]

  • Selective decreases in CA2 inhibition are associated with schizophrenia and epilepsy, two pathological conditions in which hippocampal excitability is increased.

    “The relevance of this inhibitory drive is suggested by the findings that selective decreases in CA2 inhibition are associated with schizophrenia (Benes et al., 1998) and epilepsy (Williamson and Spencer, 1994), two pathological conditions in which hippocampal excitability is increased.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S.
Affiliations
Harvard University (US)
Corresponding author
Benes, Francine M
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
1998-07
Volume
44
Issue
2
Pages
88-97
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2078446073
Cited by
470
References
1
Citations by year
2025: 9 · 2024: 7 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 16 · 2018: 15 · 2017: 12 · 2016: 16 · 2015: 12 · 2014: 25 · 2013: 14 · 2012: 21
FWCI
11.47
Type
journal article
Language
en
Open access
closed
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (MH-42261, MH00423, P01MH031154, MH-31154)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
non-pyramidal neurons, pyramidal neurons, hippocampal CA2, hippocampal formation, schizophrenia, bipolar disorder, neuronal density, stratum pyramidale, postmortem brain, psychosis pathophysiology
MeSH terms
Adult, Aged, Bipolar Disorder, Cell Count, Female, Hippocampus, Humans, Male, Middle Aged, Neurons, Schizophrenia, Antipsychotic Agents, Pyramidal Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review